Net Income (Loss) Attributable to Parent of Innovation1 Biotech Inc. from 31 Aug 2014 to 29 Feb 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Innovation1 Biotech Inc. quarterly and annual Net Income (Loss) Attributable to Parent in USD history and change rate from 31 Aug 2014 to 29 Feb 2024.
  • Innovation1 Biotech Inc. Net Income (Loss) Attributable to Parent for the quarter ending 29 Feb 2024 was $289,744, a 52% increase year-over-year.
  • Innovation1 Biotech Inc. Net Income (Loss) Attributable to Parent for the twelve months ending 29 Feb 2024 was $5,298,181, a 87% increase year-over-year.
  • Innovation1 Biotech Inc. annual Net Income (Loss) Attributable to Parent for 2023 was $5,988,266, a 85% increase from 2022.
  • Innovation1 Biotech Inc. annual Net Income (Loss) Attributable to Parent for 2022 was $40,877,813, a 4031% decline from 2021.
  • Innovation1 Biotech Inc. annual Net Income (Loss) Attributable to Parent for 2021 was $1,039,932.
Source SEC data
View on sec.gov
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

Innovation1 Biotech Inc. Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $5,298,181 $289,744 +$313,645 +52% 01 Dec 2023 29 Feb 2024 10-Q 06 May 2025 2024 Q2
Q4 2023 $5,611,826 $255,228 +$376,438 +60% 01 Sep 2023 30 Nov 2023 10-Q 06 May 2025 2024 Q2
Q3 2023 $5,988,264 $4,454,352 +$32,794,679 +88% 01 Jun 2023 31 Aug 2023 10-K 17 Jan 2024 2023 FY
Q2 2023 $38,782,943 $298,857 +$1,311,019 +81% 01 Mar 2023 31 May 2023 10-K 17 Jan 2024 2023 FY
Q1 2023 $40,093,962 $603,389 +$1,175,665 +66% 01 Dec 2022 28 Feb 2023 10-Q 06 May 2025 2024 Q2
Q4 2022 $41,269,627 $631,666 -$391,813 -163% 01 Sep 2022 30 Nov 2022 10-Q 06 May 2025 2024 Q2
Q3 2022 $40,877,814 $37,249,031 -$36,375,969 -4166% 01 Jun 2022 31 Aug 2022 10-K 17 Jan 2024 2023 FY
Q2 2022 $4,501,845 $1,609,876 -$2,406,032 -302% 01 Mar 2022 31 May 2022 10-K 17 Jan 2024 2023 FY
Q1 2022 $2,095,813 $1,779,054 -$2,337,004 -419% 01 Dec 2021 28 Feb 2022 10-K 17 Jan 2024 2023 FY
Q4 2021 $241,191 $239,853 -$2,585 -1.1% 01 Sep 2021 30 Nov 2021 10-K 17 Jan 2024 2023 FY
Q3 2021 $243,776 $873,062 -$138,267 -19% 01 Jun 2021 31 Aug 2021 10-K 15 Dec 2022 2022 FY
Q2 2021 $382,043 $796,156 +$741,945 +1369% 01 Mar 2021 31 May 2021 10-K 15 Dec 2022 2022 FY
Q1 2021 $359,902 $557,950 +$2,187,585 01 Dec 2020 28 Feb 2021 10-K 15 Dec 2022 2022 FY
Q4 2020 $2,547,487 $237,268 +$32,581 +12% 31 Aug 2020 30 Nov 2020 10-Q 15 Apr 2022 2022 Q2
Q3 2020 $2,580,068 $734,795 -$665,440 -959% 01 Jun 2020 31 Aug 2020 10-K 10 Dec 2021 2021 FY
Q2 2020 $1,914,628 $54,211 +$76,668 01 Mar 2020 31 May 2020 10-Q 13 Jul 2021 2021 Q3
Q1 2020 $1,991,296 $1,629,635 -$1,642,788 -12490% 01 Dec 2019 29 Feb 2020 10-Q 14 Apr 2021 2021 Q2
Q4 2019 $348,508 $269,849 -$178,441 -195% 01 Sep 2019 30 Nov 2019 10-Q 13 Jul 2021 2021 Q3
Q3 2019 $170,067 $69,355 +$742,534 +91% 01 Jun 2019 31 Aug 2019 10-K 15 Dec 2020 2020 FY
Q2 2019 $912,601 $22,457 -$3,487 -18% 01 Mar 2019 31 May 2019 10-Q 20 Jul 2020 2020 Q3
Q1 2019 $909,114 $13,153 +$135,051 29 Nov 2018 28 Feb 2019 10-Q 18 Jul 2019 2019 Q3
Q4 2018 $1,044,165 $91,408 -$68,641 -301% 01 Sep 2018 30 Nov 2018 10-Q 21 Jan 2020 2020 Q1
Q3 2018 $975,524 $811,889 -$798,413 -5925% 01 Jun 2018 31 Aug 2018 10-Q 18 Jul 2019 2019 Q3
Q2 2018 $177,111 $18,970 -$14,995 -377% 01 Mar 2018 31 May 2018 10-Q 18 Jul 2019 2019 Q3
Q1 2018 $162,116 $121,898 -$117,197 -2493% 01 Dec 2017 28 Feb 2018 10-Q 15 Apr 2019 2019 Q2
Q4 2017 $44,919 $22,767 -$10,759 -90% 01 Sep 2017 30 Nov 2017 10-Q 18 Jan 2019 2019 Q1
Q3 2017 $13,476 -$6,476 -93% 20 Jul 2017 31 Aug 2017 10-K 14 Dec 2018 2018 FY
Q2 2017 $27,684 $3,975 +$11,025 +74% 01 Mar 2017 31 May 2017 10-Q 24 Jul 2017 2017 Q3
Q1 2017 $38,709 $4,701 +$463 +9% 01 Dec 2016 28 Feb 2017 10-Q 14 Apr 2017 2017 Q2
Q4 2016 $39,172 $12,008 -$4,164 -53% 01 Sep 2016 30 Nov 2016 10-Q 17 Jan 2017 2017 Q1
Q3 2016 $35,008 $7,000 -$4,088 -140% 01 Jun 2016 31 Aug 2016 10-K/A 19 Jan 2018 2017 FY
Q2 2016 $30,920 $15,000 -$11,180 -293% 01 Mar 2016 31 May 2016 10-Q 24 Jul 2017 2017 Q3
Q1 2016 $19,740 $5,164 -$3,130 -154% 01 Dec 2015 29 Feb 2016 10-Q 14 Apr 2017 2017 Q2
Q4 2015 $16,610 $7,844 -$2,087 -36% 01 Sep 2015 30 Nov 2015 10-Q 17 Jan 2017 2017 Q1
Q3 2015 $14,523 $2,912 +$655 +18% 01 Jun 2015 31 Aug 2015 10-K/A 19 Jan 2018 2017 FY
Q2 2015 $15,178 $3,820 01 Mar 2015 31 May 2015 10-Q 07 Oct 2016 2016 Q3
Q1 2015 $2,034 01 Dec 2014 28 Feb 2015 10-Q 26 Sep 2016 2016 Q2
Q4 2014 $5,757 01 Sep 2014 30 Nov 2014 10-Q 12 Feb 2016 2016 Q1
Q3 2014 $3,567 01 Aug 2014 31 Aug 2014 10-K/A 19 Jan 2018 2017 FY

Innovation1 Biotech Inc. Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $5,988,266 +$34,889,547 +85% 01 Sep 2022 31 Aug 2023 10-K 17 Jan 2024 2023 FY
2022 $40,877,813 -$41,917,745 -4031% 01 Sep 2021 31 Aug 2022 10-K 17 Jan 2024 2023 FY
2021 $1,039,932 +$3,620,000 01 Sep 2020 31 Aug 2021 10-K 15 Dec 2022 2022 FY
2020 $2,580,068 -$2,410,001 -1417% 01 Sep 2019 31 Aug 2020 10-K 10 Dec 2021 2021 FY
2019 $170,067 +$805,457 +83% 01 Sep 2018 31 Aug 2019 10-K 15 Dec 2020 2020 FY
2018 $975,524 -$939,674 -2621% 01 Sep 2017 31 Aug 2018 10-K 17 Dec 2019 2019 FY
2017 $35,850 -$842 -2.4% 01 Sep 2016 31 Aug 2017 10-K/A 19 Jan 2018 2017 FY
2016 $35,008 -$20,485 -141% 01 Sep 2015 31 Aug 2016 10-K/A 19 Jan 2018 2017 FY
2015 $14,523 01 Sep 2014 31 Aug 2015 10-K/A 19 Jan 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.